Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 80.98% | -1,076.70% | -2,623.21% | -14.15% | -1,765.07% |
| Total Depreciation and Amortization | 263.18% | 4.03% | -7.01% | -17.47% | -133.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -133.93% | 1,529.62% | 13,787.73% | 230.13% | 8,219.07% |
| Change in Net Operating Assets | 346.32% | -789.49% | -1.15% | 15.74% | 71.23% |
| Cash from Operations | -3.96% | -731.78% | -67.62% | 33.79% | -36.47% |
| Capital Expenditure | 40.99% | 5.91% | -52.94% | -21.09% | 55.84% |
| Sale of Property, Plant, and Equipment | 265.84% | 3.56% | 3.61% | -65.92% | -182.73% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -233.35% | -128.14% | 61.84% | -73.48% | -135.87% |
| Cash from Investing | 644.90% | -45.15% | -50.46% | -2,477.54% | -34.41% |
| Total Debt Issued | -42.06% | 31.21% | 84.56% | 279.02% | -- |
| Total Debt Repaid | 36.38% | 17.30% | -52.25% | -372.11% | -1,578.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -352.09% | 8,914.95% | 86.47% | 58.49% | -1,355.13% |
| Cash from Financing | -172.64% | 190.74% | 140.52% | 74.00% | 15.85% |
| Foreign Exchange rate Adjustments | 109.85% | -103.12% | 2,067.19% | 187.70% | -216.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,017.31% | 84.41% | 559.85% | 572.02% | -212.93% |